ClinicalTrials.govpublic full text
The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT
acute myeloid leukemia with flt3/itd mutation, allogeneic hematopoietic stem cell transplantation, hematopoietic stem cell transplantation, gut microbiome, sorafenib, flt3-itd, acute myeloid leukemia, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 982691
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.